Text size The deal comes ahead of GlaxoSmithKline’s planned spinoff of its consumer health division in July. AFP via Getty Images GlaxoSmithKline has agreed to buy U.S. rare cancer therapy compa...
Tag: life sciences
Pfizer’s New CFO David Denton Negotiated One of the Biggest Healthcare Deals in History
Pfizer on Monday named a new chief financial officer with a resume that hints at the company’s plans to spend big with its Covid-19 vaccine windfall. David Denton is taking up the CFO role at Pfizer (...
Constellation Brands and Murphy Oil Raised Their Dividends This Week
Text size This week was a slow one for dividend increase announcements. Freeze Frames/Dreamstime.com Constellation Brands and Murphy Oil were among the small number of companies that declared dividend...
Discovery, Merck, Carnival, Broadcom, and Other Stocks to Watch This Week
Text size Uncredited It’s a full week of annual shareholder meetings, investor days, and earnings reports. Broadcom hosts its annual meeting on Monday, followed by investor events from Merck, Analog D...
Discovery, Merck, Carnival, Broadcom, and Other Stocks for Investors to Watch This Week
Text size Uncredited It’s a full week of annual shareholder meetings, investor days, and earnings reports. Broadcom hosts its annual meeting on Monday, followed by investor events from Merck, Analog D...
Biotech Stocks Are Cheap. Is It Time for Blockbuster M&A?
Biotech stocks took a beating over the past 12 months, but their cheap valuations could be good entry points for investors, experts say. It could also open them up for opportunities to be acquired or ...
Biotech Stocks Could Rally – TheStreet
Biotech stocks took a beating over the past 12 months, but their cheap valuations could be good entry points for investors, experts say. The outlook for biotech stocks is positive in part because the ...
Stocks for the Recession That May—or May Not—Be Coming
Text size Exelon stock offers a little bit of offense to go with its defense. Dreamstime The yield curve briefly inverted this past week—and that’s a recession signal that is either like Paul Revere’s...
Cathie Wood Watch: Ark Buys Into Drug-Discovery, Protein-Testing Firms
The prominent asset manager Cathie Wood, chief executive of Ark Investment Management, on Wednesday bought into a drug-discovery-technology stock, again bulked up on a major cryptocurrency stock, and ...
Cathie Wood Watch: Ark Buys Crypto Stock, Buys and Sells EVs
Asset manager Cathie Wood, chief executive of Ark Investment Management, traded again on Tuesday, buying a major cryptocurrency stock and selling shares of a big electric vehicle maker. She also conti...
Pfizer, Moderna and J&J Face Shareholder Pressure to Broaden Covid-19 Vaccine Access
Socially conscious investors and global-health activists are turning to shareholders to press Covid-19 vaccine manufacturers Pfizer Inc., Moderna Inc. and Johnson & Johnson to make more of their s...
Cathie Wood Buys Into a Biotech With a Covid Connection
Star investor Cathie Wood, chief executive of Ark Investment Management, has recently built a stake in a biotechnology company that earlier this month received a dose of good news. The stock is Adapti...
Investors have been scared out of this group of stocks, says fund manager, who offers five ideas for the rebound to come.
China has been talking up its markets, and that’s lifting all boats this morning, with Wall Street off to a strong start ahead of what’s expected to be the first Fed rate hike in more than three years...
Cathie Wood Watch: Ark Buys Biotech Stocks
Investment star Cathie Wood, chief executive of Ark Investment Management, on Tuesday had focused some of her buying on biotechnology stocks. Recent purchases including Atai Life Sciences (ATAI) R...
Novavax’s Revenue Falls Short. Management Expects a Surge.
Text size A doctor handles a vial holding a potential coronavirus vaccine at a Novavax lab in 2020. Andrew Caballero-Reynolds/AFP via Getty Images The Covid-19 vaccine maker Novavax expects sales of b...
Covid-19 Vaccine Makers Face a New Rival as GlaxoSmithKline and Sanofi Prepare to Enter the Ring
As new Covid-19 cases fall, the postpandemic vaccine market grows more interesting. On Wednesday, GlaxoSmithKline and Sanofi, two of the world’s largest vaccine makers, said they would submit a Covid ...
12 dividend stocks paying at least 3.5% that are well-suited for high inflation
Investors may have turned for a moment from Russia’s aggression in Ukraine to energy and supply shortages in the U.S. that are producing high inflation. With purchasing power crumbling, patient invest...